In news
The first National Heart Failure Biobank (NHFB) in the country that would collect blood, biopsies, and clinical data as a guide to future therapies was inaugurated at the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST).
Details
- “There are no heart failure biobanks in the country, and this would greatly help in guiding future therapies and technologies and would benefit the heart failure patients significantly.
- The biobank will provide insights into heart diseases and heart failure among Indian children and adults, which are very different from that seen in the West.
- NHFB would prove very helpful in understanding molecular pathways and would improve the diagnosis, prognosis, and treatment of Heart Failure.
- “It will open a new era in research in Heart Failure in India and will change the persona of diagnosis and treatment of heart failure patients.
- The facility will be useful for the research and treatment of post-covid heart failure.
- The increase in the observed prevalence of long-COVID symptoms and post-COVID heart failure calls for long-COVID clinics to collect patient data and biospecimens that can be biobank for future research.
- Through the NHFB, researchers can get access to well-annotated biological specimens linked to clinical data while maintaining appropriate standards of quality and security
Source: PIB
.jpg)
